AAAAAA

   
Results: 1-7 |
Results: 7
Two-step targeting of xenografted colon carcinoma using a bispecific antibody and Re-188-labeled bivalent hapten: Biodistribution and dosimetry studies
Authors: Gestin, JF Loussouarn, A Bardies, M Gautherot, E Gruaz-Guyon, A Sai-Maurel, C Barbet, J Curtet, C Chatal, JF Faivre-Chauvet, A
Citation: Jf. Gestin et al., Two-step targeting of xenografted colon carcinoma using a bispecific antibody and Re-188-labeled bivalent hapten: Biodistribution and dosimetry studies, J NUCL MED, 42(1), 2001, pp. 146-153
Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer
Authors: Hosono, MN Hosono, M Mishra, AK Faivre-Chauvet, A Gautherot, E Barbet, J Knapp, FF Chatal, JF
Citation: Mn. Hosono et al., Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer, ANN NUCL M, 14(3), 2000, pp. 173-179
Synthesis of a novel bifunctional chelating agent for actinium complexation
Authors: Ouadi, A Loussouarn, A Remaud, P Morandeau, L Apostolidis, C Musikas, C Faivre-Chauvet, A Gestin, JF
Citation: A. Ouadi et al., Synthesis of a novel bifunctional chelating agent for actinium complexation, TETRAHEDR L, 41(37), 2000, pp. 7207-7209
Validation of Bi-213-alpha radioimmunotherapy for multiple myeloma
Authors: Couturier, O Faivre-Chauvet, A Filippovich, IV Thedrez, P Sai-Maurel, C Bardies, M Mishra, AK Gauvrit, M Blain, G Apostolidis, C Molinet, R Abbe, JC Bataille, R Wijdenes, J Chatal, JF Cherel, M
Citation: O. Couturier et al., Validation of Bi-213-alpha radioimmunotherapy for multiple myeloma, CLIN CANC R, 5(10), 1999, pp. 3165S-3170S
Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections
Authors: Kraeber-Bodere, F Faivre-Chauvet, A Sai-Maurel, C Campion, L Fiche, M Gautherot, E Le Boterff, J Barbet, J Chatal, JF Thedrez, P
Citation: F. Kraeber-bodere et al., Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections, CLIN CANC R, 5(10), 1999, pp. 3183S-3189S
Two-step targeting and dosimetry for small cell lung cancer xenograft withanti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten
Authors: Hosono, M Hosono, MN Kraeber-Bodere, F Devys, A Thedrez, P Faivre-Chauvet, A Gautherot, E Barbet, J Chatal, JF
Citation: M. Hosono et al., Two-step targeting and dosimetry for small cell lung cancer xenograft withanti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten, J NUCL MED, 40(7), 1999, pp. 1216-1221
Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft
Authors: Kraeber-Bodere, F Faivre-Chauvet, A Sai-Maurel, C Gautherot, E Fiche, M Campion, L Le Boterff, J Barbet, J Chatal, JF Thedrez, P
Citation: F. Kraeber-bodere et al., Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft, J NUCL MED, 40(1), 1999, pp. 198-204
Risultati: 1-7 |